COUR Pharmaceuticals: Responding to the Unique Challenges of Rare Diseases
Finding the right people focused on rare diseases is not straightforward and can require resource-constrained teams to prioritize just a handful of experts. Malcolm Crooks, one of the industry’s leading innovators and the COO of COUR Pharmaceuticals discusses the challenges in finding the right people to engage with and turning that into treatments for patients.
